These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11192826)

  • 1. Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer.
    Lissoni P; Fugamalli E; Malugani F; Ardizzoia A; Secondino S; Tancini G; Gardani GS
    Int J Biol Markers; 2000; 15(4):308-11. PubMed ID: 11192826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer.
    Bonfanti A; Lissoni P; Bucovec R; Rovelli F; Brivio F; Fumagalli L
    Int J Biol Markers; 2000; 15(2):161-4. PubMed ID: 10883890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic activity of melatonin in advanced cancer patients.
    Lissoni P; Rovelli F; Malugani F; Bucovec R; Conti A; Maestroni GJ
    Neuro Endocrinol Lett; 2001; 22(1):45-7. PubMed ID: 11335879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
    Dirix LY; Vermeulen PB; Pawinski A; Prové A; Benoy I; De Pooter C; Martin M; Van Oosterom AT
    Br J Cancer; 1997; 76(2):238-43. PubMed ID: 9231925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
    Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
    Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
    Dunst J; Pigorsch S; Hänsgen G; Hintner I; Lautenschläger C; Becker A
    Strahlenther Onkol; 1999 Mar; 175(3):93-6. PubMed ID: 10093609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
    J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels.
    Colleoni M; Rocca A; Sandri MT; Zorzino L; Masci G; Nolè F; Peruzzotti G; Robertson C; Orlando L; Cinieri S; de BF; Viale G; Goldhirsch A
    Ann Oncol; 2002 Jan; 13(1):73-80. PubMed ID: 11863115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) serum levels during cancer immunotherapy with IL-2: preliminary considerations.
    Lissoni P; Fumagalli L; Giani L; Rovelli F; Confalonieri G; Pescia S
    Int J Biol Markers; 1998; 13(2):98-101. PubMed ID: 9803358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
    Coskun U; Günel N; Toruner FB; Sancak B; Onuk E; Bayram O; Cengiz O; Yilmaz E; Elbeg S; Ozkan S
    Neoplasma; 2003; 50(1):41-6. PubMed ID: 12687277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer.
    Tamura M; Ohta Y; Kajita T; Kimura K; Go T; Oda M; Nakamura H; Watanabe G
    Oncol Rep; 2001; 8(5):1097-102. PubMed ID: 11496323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancer.
    Lissoni P; Rovelli F; Malugani F; Brivio F; Fumagalli L; Gardani GS
    Int J Biol Markers; 2003; 18(2):152-5. PubMed ID: 12841685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate markers of tumoral angiogenesis.
    Byrne GJ; Bundred NJ
    Int J Biol Markers; 2000; 15(4):334-9. PubMed ID: 11192830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.
    Hyodo I; Doi T; Endo H; Hosokawa Y; Nishikawa Y; Tanimizu M; Jinno K; Kotani Y
    Eur J Cancer; 1998 Dec; 34(13):2041-5. PubMed ID: 10070308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?
    Wynendaele W; Derua R; Hoylaerts MF; Pawinski A; Waelkens E; de Bruijn EA; Paridaens R; Merlevede W; van Oosterom AT
    Ann Oncol; 1999 Aug; 10(8):965-71. PubMed ID: 10509160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer.
    Lebrecht A; Ludwig E; Huber A; Klein M; Schneeberger C; Tempfer C; Koelbl H; Hefler L
    Gynecol Oncol; 2002 Apr; 85(1):32-5. PubMed ID: 11925116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines.
    Lissoni P; Bucovec R; Malugani F; Ardizzoia A; Villa S; Gardani GS; Vaghi M; Tancini G
    Anticancer Res; 2002; 22(2B):1131-4. PubMed ID: 12168912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H
    Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer.
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Yamashita H; Fukuda M
    Breast Cancer; 2003; 10(2):120-8. PubMed ID: 12736564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
    Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
    Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.